Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Leukaemias
ADR ID BADD_A02515
ADR Hierarchy
01      Blood and lymphatic system disorders
01.10      Leukaemias
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.01      Leukaemias
Description Not Available
MedDRA Code 10024324
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Not Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02203Thiotepa--
BADD_D02214Ticagrelor0.000272%
BADD_D02215Ticlopidine--
BADD_D02216Ticlopidine hydrochloride--
BADD_D02236Tofacitinib0.000603%
BADD_D02241Tolcapone--
BADD_D02246Tolvaptan0.000058%
BADD_D02249Topotecan hydrochloride--
BADD_D02252Tositumomab--
BADD_D02253Trabectedin0.000112%
BADD_D02270Tretinoin0.000534%
BADD_D02329Valproic acid0.000150%
BADD_D02331Valsartan0.000328%
BADD_D02337Varenicline0.000195%
BADD_D02344Vemurafenib0.000694%
BADD_D02345Venetoclax0.025867%
BADD_D02360Vincristine0.000392%
BADD_D02361Vincristine sulfate--
BADD_D02369Voriconazole0.177160%
BADD_D02370Vorinostat0.000112%
BADD_D02375Water--
BADD_D02383Zidovudine0.013262%
BADD_D02392Zoledronic acid0.005726%
BADD_D02412Octreotide0.000279%
BADD_D02436Atorvastatin--
BADD_D02442Magnesium oxide0.000365%
BADD_D02443Tiotropium0.000086%
BADD_D02453Midostaurin0.001421%
BADD_D02464Fingolimod0.000241%
BADD_D02470Nintedanib0.000392%
The 7th Page    First    Pre   7 8    Next   Last    Total 8 Pages
ADReCS-Target
ADR Term Drug Name Target